SWOT Analysis for Novartis India Ltd. - Opportunity

Add SWOT widget to your site/app

MACD Crossover Above Signal Line

Companies with no Debt

Benjamin Graham Value Screen

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Newly Affordable Stocks with Good Financials and Durability (subscription)

Mid-range Performer (DVM)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Zero Promoter Pledge

Recent Results : Growth in Operating Profit with increase in operating margins (YoY)

Decrease in Provision in recent results

MACD crossed above signal line previous end of day

Top Gainers

Volume Shockers

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Declining Net Cash Flow : Companies not able to generate net cash

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Increased Shareholding in Past Month

Companies with improving valuation scores after share price falls

Mutual Funds Increased Shareholding over the Past Two Months

Mf buying for 2 months

High Piotroski Score - Companies with strong financials

Rising Delivery Percentage Compared to Prev Day

Bullish or Bearish Candlestick Strength - Indices

Bullish Harami (Bullish Reversal)

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)